Azacitidine for Treating Acute Myeloid Leukaemia with More Than 30 % Bone Marrow Blasts: An Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology Appraisal

Irina A. Tikhonova*, Martin W. Hoyle, Tristan M. Snowsill, Chris Cooper, Joanna L. Varley-Campbell, Claudius E. Rudin, Ruben E. Mujica Mota

*Corresponding author for this work

Research output: Contribution to journalReview article (Academic Journal)peer-review

4 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Azacitidine for Treating Acute Myeloid Leukaemia with More Than 30 % Bone Marrow Blasts: An Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology Appraisal'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions